SCHEMBL7969485

SCHEMBL7969485

Cc1cc(C)c(Nc2nc3ccccc3n3cncc23)c(C)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 1.00
SRC P12931 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987291 0.92 LCK (1.00) LCK
SCHEMBL7969626 0.90 LCK (0.82) LCK
SCHEMBL7980767 0.90 LCK (1.00) LCK
SCHEMBL7980244 0.88 LCK (0.78) LCK
SCHEMBL7982979 0.85 LCK (0.79) LCK
SCHEMBL7970124 0.84 LCK (0.72) LCKSRC
SCHEMBL4036154 0.83 LCK (0.71) LCKSRC
SCHEMBL7983700 0.83 LCK (0.84) LCK
SCHEMBL7969689 0.82 LCK (0.75) LCK
SCHEMBL8477340 0.82 LCK (0.85) LCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed